Beyond Outsourcing: Turning Your CDMO Into A Value-Creation Engine

Biopharma and emerging biotech companies face mounting pressure to advance innovative therapies while managing complex scientific, financial, and operational demands. This webinar explores the key trends shaping today's drug development landscape, including shifting licensing activity, strategic partnerships, and the expanding role of contract development and manufacturing organizations (CDMOs) in bringing programs forward.

Industry experts unpack the factors that shape planning decisions, from chemistry, manufacturing, and controls (CMC) strategy and due diligence to process scalability, regulatory readiness, and risk management. The discussion also looks at how teams can strengthen collaboration across each phase, sharpen operational efficiency, and position their pipelines for upcoming milestones. Speakers additionally address how to align financial planning with clinical timelines, offering perspectives on funding flexibility and capital management that help sustain momentum across the product lifecycle.

Designed for biotech executives, technical leaders, business development professionals, and drug development teams, this session delivers practical insight into today's environment and the strategic choices that help companies manage complexity, build readiness, and set their programs up for long-term success.